contact  |  disclaimer  |  intranet

 

  Home

 

  

  SARS

 

   • Introduction

 • Outbreak

 • 2003 SARS epidemic

 • Virus hunting

 • Coronaviruses

 • Virus evolution

 • Control

 • Novel coronaviruses

 • Future research

 

 

     

SARS-DTV consortium

  (Documents from the year  2004

  when SARS-DTV research started)

 • SARS-DTV research plan

 • SARS-DTV: who we are

 • SARS-DTV leaflet

 • Contact information

  

  SARS-DTV publications

  (2004-2008)

 

  SARS-DTV final report

  (2008)

 

 

 

  Useful links

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Last update: October 2005

 

  

 

 

 

 

 

 

 

Partner 6 - Queen’s University Belfast

Prof. John Ziebuhr is acknowledged as an expert in coronavirus enzymology. He has studied coronavirus replicative enzymes at the University of Würzburg for about 15 years. In January 2006, his group will move to laboratories at the School of Biomedical Sciences (Center for Cancer Research and Cell Biology) at the Queen's University in Belfast. His research has made important contributions to the elucidation of coronavirus replicase processing pathways and the characterization of the enzymatic properties of coronavirus proteases. Furthermore, his work on coronavirus proteases contributed to the determination and interpretation of crystal structures of coronavirus main proteases and the structure of a  complex of transmissible gastroenteritis (corona)virus main protease with a peptidyl chloromethyl ketone inhibitor. This structure information is now used in several collaborations to develop coronavirus-specific protease inhibitors by rational drug design. Professor Ziebuhr's laboratory also has broad expertise in the heterologous expression and characterization of enzymes involved in nidovirus RNA metabolism. The present work of the group focuses mainly on coronavirus RNA-processing enzymes (helicases, ribonucleases, nucleotide phosphatases, and others) of human coronaviruses (HCoV-229E, SARS-CoV, HCoV-NL63) using biochemical and reverse-genetics approaches. Over the years, Professor Ziebuhr coordinated numerous research projects and his work has led to publications in excellent peer-reviewed journals (e.g., EMBO J., J. Biol. Chem., Science, PNAS, RNA, J. Virol., J. Mol. Biol., PLoS Biology).

 

Selected publications of partner 6:

  • Ivanov, K. A., Hertzig, T., Rozanov, M., Bayer, S., Thiel, V., Gorbalenya, A. E., and Ziebuhr, J. 2004. Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc. Natl. Acad. Sci. USA 101:12694-12699.
  • Ivanov, K. A., Thiel, V., Dobbe, J. C., van der Meer, Y., Snijder, E. J., and Ziebuhr, J. 2004. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase. J. Virol. 78:5619-5632.
  • Putics, A., Filipowicz, W., Hall, J., Gorbalenya, A. E., and Ziebuhr, J. 2005. ADP-ribose-1"-monophosphatase: a conserved coronavirus enzyme that is dispensable for viral replication in tissue culture. J. Virol. 79:12721-12731.
  • Thiel, V., Ivanov, K. A., Putics, A., Hertzig, T., Schelle, B., Bayer, S., Weissbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E., and Ziebuhr, J. 2003. Mechanisms and enzymes involved in SARS coronavirus genome expression. J. Gen. Virol. 84:2305-2315.
  • Ziebuhr, J. 2004. Molecular biology of severe acute respiratory syndrome coronavirus. Curr. Opin. Microbiol. 7:412-419.

 

Prof. John Ziebuhr

j.ziebuhr@qub.ac.uk

Dr. Ekaterina Minskaia

Rachel Ulferts

Tobias Hertzig